Original document(35 pages) Authorized document(35 pages) 中文版
    The present invention discloses the new use of gene mutant of human telomerase inverse transcriptase-like component in preparing liver cancer treating medicine. The gene mutant has gene sequence including various possible mutant sequence in the conservative structures of telomerase inverse transcriptase-like component; and its carrier is eukaryotic expression plasmid or nucleic acid virus. As medicine, the administration mode is intravenous injection or intramuscular injection.
Application Number
申请号		 02110521 Application Date
申请日		 2002.01.09
Title 名称 New use of gens mutant of human telomerase inverse transcriptase-like component
Publication Number
公开号		 1432411 Publication Date
公开日		 2003.07.30
Approval Pub. Date 2006.05.10 Granted Pub. Date 2006.05.10
International Classification 分类号 A61K48/00,C12N15/86,A61P35/00
Applicant(s) Name
申请人		 Shanghai Inst. of Cytobiology, Chinese Academy of Sciences
Address 地址 200031
Inventor(s) Name 发明人 Xie Hong, Zhang Rugang
Attorney & Agent 代理人 xiao jiannan
More information 更  多  信  息


 Related patents information
Chemical vapor deposited spherical reductive iron
Anti-virus immunological milk
Immune milk with anti human body G-I tract pathogenic microorganism function
Immunity dairy products of prevention of human body alimentary canal pathogeny microorganism
Mouse antiamboceptor medicinal radionuclide I-131
Mouse antiamboceptor medicinal radionuclide Y-90
Mouse antiamboceptor medicinal radionuclide s-35
Medicinal radiative nuclear element by monoclone antibody of mouse liver cancer
Liver cancer murine monoclone antibody without endogenous immunoglobulin and its preparation and application
Dual compressed video bitstream camera for universal serial bus connection
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.